Back
Kimberly-Clark Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
45
KMB
Kimberly-Clark
Last Price:
142.50
Seasonality Move:
4.42%
Sell
45
MIRM
Mirum Pharmaceuticals
Last Price:
38.87
Seasonality Move:
5.99%
Sell
45
Kimberly-Clark (KMB)
is a Sell
Is Kimberly-Clark a Buy, Sell or Hold?
- The current Kimberly-Clark [KMB] share price is $142.18. The Score for KMB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- KMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $38.72. The Score for MIRM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KMB Stock Price Chart
What is Kimberly-Clark's stock price today?
-
The Kimberly-Clark share price today is $142.18
The current trend is relatively stagnant and KMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $38.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.
KMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 48.23 | Sell |
| Chaikin Money Flow: | 825098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (141.39 - 146.15) | Sell |
| Bollinger Bands (100): | (135.38 - 143.68) | Buy |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 41.61 | Sell |
| Chaikin Money Flow: | -57139 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.33 - 42.57) | Sell |
| Bollinger Bands (100): | (28.23 - 41.85) | Buy |
KMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 141.16 | Buy |
| 20-day SMA: | 143.73 | Sell |
| 50-day SMA: | 142.17 | Buy |
| 200-day SMA: | 131.91 | Buy |
| 8-day EMA: | 141.75 | Buy |
| 20-day EMA: | 142.58 | Sell |
| 50-day EMA: | 141.88 | Buy |
| 200-day EMA: | 135.14 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.01 | Sell |
| 20-day SMA: | 40.52 | Sell |
| 50-day SMA: | 40.71 | Sell |
| 200-day SMA: | 31.23 | Buy |
| 8-day EMA: | 39.24 | Sell |
| 20-day EMA: | 40.05 | Sell |
| 50-day EMA: | 39.32 | Sell |
| 200-day EMA: | 33.16 | Buy |
Kimberly-Clark Earnings Growth & KMB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.14 per share, an increase this year of $0.69 per share, and an increase next year of $0.35 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Kimberly-Clark Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||